BioCentury
ARTICLE | Company News

Xanthon, Xenometrix in patent licensing deal

July 9, 2001 7:00 AM UTC

Xenometrix, a wholly owned subsidiary of Discovery Partners (DPII), granted Xanthon ( Research Triangle Park, N.C.) a non-exclusive license to its gene expression profiling patents. ...